A Multi-Center, Double-Blind, Fixed Dose Trial Examining the Efficacy and Safety of Org 25935 Versus Placebo as Augmentation to Cognitive Behavioral Therapy in Subjects With Panic Disorder.

Trial Profile

A Multi-Center, Double-Blind, Fixed Dose Trial Examining the Efficacy and Safety of Org 25935 Versus Placebo as Augmentation to Cognitive Behavioral Therapy in Subjects With Panic Disorder.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs ORG 25935 (Primary)
  • Indications Panic disorder
  • Focus Therapeutic Use
  • Sponsors Organon; Schering-Plough
  • Most Recent Events

    • 12 Feb 2012 Results published in the Journal of Clinical Psychiatry.
    • 01 Jun 2010 Planned end date changed from Aug 2010 to Apr 2010 as reported by ClinicalTrials.gov.
    • 10 Mar 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top